HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheng-Nan Wu Selected Research

Idiopathic Pulmonary Fibrosis

9/2020Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheng-Nan Wu Research Topics

Disease

21Pituitary Neoplasms (Pituitary Adenoma)
08/2022 - 05/2003
10Seizures (Absence Seizure)
04/2021 - 03/2008
8Glioma (Gliomas)
01/2021 - 06/2002
7Neuroblastoma
08/2022 - 06/2002
6Neoplasms (Cancer)
03/2024 - 01/2012
6Epilepsy (Aura)
07/2022 - 01/2018
4Neuralgia (Stump Neuralgia)
08/2022 - 01/2019
4Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2014
4Status Epilepticus (Complex Partial Status Epilepticus)
08/2019 - 01/2009
4Schizophrenia (Dementia Praecox)
10/2012 - 08/2004
3Inflammation (Inflammations)
03/2016 - 04/2011
2Breast Neoplasms (Breast Cancer)
03/2024 - 10/2020
2Hypoxia (Hypoxemia)
08/2021 - 11/2019
2Brain Neoplasms (Brain Tumor)
01/2021 - 10/2019
2Multiple Sclerosis
10/2020 - 01/2018
2Pheochromocytoma
07/2020 - 03/2004
2Insulin Resistance
01/2020 - 08/2012
2Pain (Aches)
01/2018 - 10/2006
2Hypertension (High Blood Pressure)
01/2016 - 07/2007
2Acute Lung Injury
01/2013 - 04/2011
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2008 - 04/2003
1Nervous System Diseases (Neurological Disorders)
02/2024
1Homocystinuria
12/2023
1Methylmalonic acidemia
12/2023
1Cytopenia
11/2023
1Virus Diseases (Viral Diseases)
11/2023
1Hyperplasia
11/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2023
1Hemorrhagic Cystitis
11/2023
1COVID-19
10/2023
1Headache (Headaches)
10/2023
1Diarrhea
10/2023
1Nausea
10/2023
1Systolic Heart Failure
05/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1Cardiac Arrhythmias (Arrythmia)
01/2023
1Left Ventricular Dysfunction
01/2023
1Autoimmune Diseases of the Nervous System
06/2022
1Diabetic Neuropathies (Diabetic Neuropathy)
03/2022
1Congenital Heart Defects (Congenital Heart Defect)
01/2022
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2021
1Urinary Incontinence
11/2021

Drug/Important Bio-Agent (IBA)

11Pilocarpine (Ocusert)FDA LinkGeneric
04/2021 - 01/2009
7Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
01/2021 - 08/2002
6LithiumIBA
04/2021 - 01/2009
4Anticonvulsants (Antiepileptic Drugs)IBA
07/2022 - 01/2013
4CationsIBA
07/2020 - 01/2019
3Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2018
3PlatinumIBA
08/2022 - 07/2009
3Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2022 - 07/2009
3Ion Channels (Ion Channel)IBA
06/2022 - 01/2015
3Antineoplastic Agents (Antineoplastics)IBA
08/2021 - 10/2014
3Cilostazol (Pletal)FDA LinkGeneric
01/2021 - 03/2004
3Glucose (Dextrose)FDA LinkGeneric
07/2020 - 08/2012
3AminesIBA
10/2014 - 02/2003
2Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2023
2Carbamazepine (Tegretol)FDA LinkGeneric
07/2022 - 11/2020
2Muscarinic AntagonistsIBA
11/2021 - 04/2008
2Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
01/2021 - 03/2004
2Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA
01/2021 - 07/2015
2Insulin (Novolin)FDA Link
02/2020 - 01/2018
2Adenosine Triphosphate (ATP)IBA
01/2020 - 05/2010
2Peptides (Polypeptides)IBA
01/2019 - 01/2018
2Messenger RNA (mRNA)IBA
01/2016 - 09/2014
2NitrogenIBA
02/2015 - 01/2015
2Diphosphonates (Bisphosphonates)IBA
02/2015 - 01/2015
2Heparin (Liquaemin)FDA LinkGeneric
01/2013 - 04/2011
2CholesterolIBA
01/2011 - 02/2006
2SesquiterpenesIBA
04/2008 - 02/2003
2RiluzoleFDA LinkGeneric
01/2008 - 04/2003
1XAV939IBA
03/2024
1TankyrasesIBA
03/2024
1Syntex adjuvant formulationIBA
02/2024
1ProdrugsIBA
10/2023
1molnupiravirIBA
10/2023
1Sodium Channels (Sodium Channel)IBA
10/2023
1Myosins (Myosin)IBA
05/2023
1omecamtiv mecarbilIBA
05/2023
1PTX3 proteinIBA
01/2023
1picaridinIBA
08/2022
1diphenyl (biphenyl)IBA
08/2022
1honokiolIBA
08/2022
1Phenobarbital (Luminal)FDA Link
08/2022
1AutoantibodiesIBA
06/2022
1mirogabalinIBA
03/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Endothelins (Endothelin)IBA
12/2021
1sparsentanIBA
12/2021
1Angiotensin IIIBA
12/2021
1Cholinergic Antagonists (Anticholinergics)IBA
11/2021
1IsoquinolinesIBA
11/2021
1Polymethyl Methacrylate (Sol)IBA
11/2021
1Solifenacin SuccinateFDA Link
11/2021
11-octylnonyl 8- ((2- hydroxyethyl)(6- oxo- 6- (undecyloxy)hexyl)amino)octanoateIBA
10/2021

Therapy/Procedure

2Transplantation
11/2023 - 03/2020
1Therapeutics
03/2024
1Neoadjuvant Therapy
03/2024
1Punctures
11/2023
1Immunotherapy
06/2022